Effects of copper deficiency on mouse yolk sac vasculature and expression of angiogenic mediators

Birth Defects Research Part B - Developmental and Reproductive Toxicology

Volumn 77, Issue 5, 2006, Pages 445-454

  Yang, Soo Jin ^a   Uriu Adams, Janet Y ^a   Keen, Carl L ^a,b   Rucker, Robert B ^a   Lanoue, Louise ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Angiogenesis; Angiogenic mediators; Cu deficiency; Vessel diameter; Yolk sac vasculature

Indexed keywords

ANGIOGENIC FACTOR; ANGIOPOIETIN 1; ANGIOPOIETIN RECEPTOR; CHELATING AGENT; COPPER; GROWTH FACTOR; MESSENGER RNA; VASCULOTROPIN; VASCULOTROPIN RECEPTOR 1; VASCULOTROPIN RECEPTOR 2;

ANGIOGENESIS; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; COPPER DEFICIENCY; EMBRYO; EMBRYO DEVELOPMENT; EMBRYO GROWTH; EVALUATION; FEMALE; GENE EXPRESSION; GESTATIONAL AGE; IMMUNOHISTOCHEMISTRY; INCIDENCE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; VASCULARIZATION; YOLK SAC;

ANGIOGENESIS INDUCING AGENTS; ANIMALS; BIOLOGICAL MARKERS; BLOOD VESSELS; COPPER; EMBRYONIC DEVELOPMENT; GENE EXPRESSION REGULATION; KIDNEY; LIVER; MICE; RNA, MESSENGER; YOLK SAC;

EID: 33750491949     PISSN: 15429733     EISSN: None     Source Type: Journal    
DOI: 10.1002/bdrb.20096     Document Type: Article

References (55)

1. Alessandri G, Raju K, Gullino PM. 1984. Angiogenesis in vivo and selective mobilization of capillary endothelium in vitro by heparin-copper complex. Microcirc Endothelium Lymphatics 1:329-346.
2. Andersen HS, Gambling L, Holtrop G, McArdle HJ. 2006. Maternal iron deficiency identifies critical windows for growth and cardiovascular development in the rat postimplantation embryo. J Nutr 136:1171-1177.
3. Araya M, Koletzko B, Uauy R. 2003. Copper deficiency and excess in infancy: developing a research agenda. J Pediatr Gastroenterol Nutr 37:422-429.
4. Argraves WS, Larue AC, Fleming PA, Drake CJ. 2002. VEGF signaling is required for the assembly but not the maintenance of embryonic blood vessels. Dev Dyn 225:298-304.
5. Argraves WS, Drake CJ. 2005. Genes critical to vasculogenesis as defined by systematic analysis of vascular defects in knockout mice. Anat Rec A Discov Mol Cell Evol Biol 286:875-884.
6. Beckers-Trapp ME, Lanoue L, Keen CL, Rucker RB, Uriu-Adams JY. 2006. Abnormal development and increased 3-nitrotyrosine in copper-deficient mouse embryos. Free Radic Biol Med 40:35-44.
7. Beckman JS, Koppenol WH. 1996. Nitric oxide, superoxide, and peroxynitrite: the good, the bad, and ugly. Am J Physiol 271:C1424-C1437.
8. Breier G. 2000. Angiogenesis in embryonic development - a review. Placenta 21(Suppl A):S11-S15.
9. Brewer GJ, Dick RD, Grover DK, LeClaire V, Tseng M, Wicha M, Pienta K, Redman BG, Jahan T, Sondak VK, Strawderman M, LeCarpentier G, Merajver SD. 2000. Treatment of metastatic cancer with tetrathiomolybdate, an anticopper, antiangiogenic agent: Phase I study. Clin Cancer Res 6:1-10.
10. Brewer GJ. 2005a. Anticopper therapy against cancer and diseases of inflammation and fibrosis. Drug Discov Today 10:1103-1109.
11. Brewer GJ. 2005b. Copper lowering therapy with tetrathiomolybdate as an antiangiogenic strategy in cancer. Curr Cancer Drug Targets 5:195-202.
12. Brooke BS, Karnik SK, Li DY. 2003. Extracellular matrix in vascular morphogenesis and disease: structure versus signal. Trends Cell Biol 13:51-56.
13. Brown NA. 1990. Routine assessment of morphology and growth: scoring system and measurements of size. In: Copp AJ, Cockroft DL, editors. Postimplantation mammalian embryos: a practical approach. Oxford: IRL Press, p 93-108.
14. Carmeliet P, Ferreira V, Breier G, Pollefeyt S, Kieckens L, Gertsenstein M, Fahrig M, Vandenhoeck A, Harpal K, Eberhardt C, Declercq C, Pawling J, Moons L, Collen D, Risau W, Nagy A. 1996. Abnormal blood vessel development and lethality in embryos lacking a single VEGF allele. Nature 380:435-439.
15. Claesson-Welsh L. 2003. Signal transduction by vascular endothelial growth factor receptors. Biochem Soc Trans 31:20-24.
16. Cleaver O, Krieg PA. 1999. Molecular mechanisms of vascular development. New York: Academic Press, p 221-252.
17. Conway EM, Collen D, Carmeliet P. 2001. Molecular mechanisms of blood vessel growth. Cardiovasc Res 49:507-521.
18. Csiszar K. 2001. Lysyl oxidases: a novel multifunctional amine oxidase family. Prog Nucleic Acid Res Mol Biol 70:1-32.
19. Damert A, Miquerol L, Gertsenstein M, Risau W, Nagy A. 2002. Insufficient VEGFA activity in yolk sac endoderm compromises hematopoietic and endothelial differentiation. Development 129:1881-1892.
20. Elsherif L, Jiang Y, Saari JT, Kang YJ. 2004. Dietary copper restriction-induced changes in myocardial gene expression and the effect of copper repletion. Exp Biol Med (Maywood) 229:616-622.
21. Ferrara N, Alitalo K. 1999. Clinical applications of angiogenic growth factors and their inhibitors. Nature Med 5:1359-1364.
22. Fong GH, Rossant J, Gertsenstein M, Breitman ML. 1995. Role of the Flt-1 receptor tyrosine kinase in regulating the assembly of vascular endothelium. Nature 376:66-70.
23. Gambling L, McArdle HJ. 2004. Iron, copper and fetal development. Proc Nutr Soc 63:553-562.
24. Harris ED. 2003. Basic and clinical aspects of copper. Crit Rev Clin Lab Sci 40:547-586.
25. Hawk SN, Uriu-Hare JY, Daston GP, Jankowski MA, Kwik-Uribe C, Rucker RB, Keen CL. 1998. Rat embryos cultured under copper-deficient conditions develop abnormally and are characterized by an impaired oxidant defense system. Teratology 57:310-320.
26. Hawk SN, Lanoue L, Keen CL, Kwik-Uribe CL, Rucker RB, Uriu-Adams JY. 2003. Copper-deficient rat embryos are characterized by low superoxide dismutase activity and elevated superoxide anions. Biol Reprod 68:896-903.
27. Holash J, Wiegand SJ, Yancopoulos GD. 1999. New model of tumor angiogenesis: dynamic balance between vessel regression and growth mediated by angiopoietins and VEGF. Oncogene 18:5356-5362.
28. Hu GF. 1998. Copper stimulates proliferation of human endothelial cells under culture. J Cell Biochem 69:326-335.
29. Jain RK. 2003. Molecular regulation of vessel maturation. Nat Med 9:685-693.
30. Kagan HM, Li W. 2003. Lysyl oxidase: properties, specificity, and biological roles inside and outside of the cell. J Cell Biochem 88:660-672.
31. Keen CL, Uriu-Hare JY, Hawk SN, Jankowski MA, Daston GP, Kwik-Uribe CL, Rucker RB. 1998. Effect of copper deficiency on prenatal development and pregnancy outcome. Am J Clin Nutr 67(Suppl):1003S-1011S.
32. Keen CL, Hanna LA, Lanoue L, Uriu-Adams JY, Rucker RB, Clegg MS. 2003. Developmental consequences of trace mineral deficiencies in rodents: acute and long-term effects. J Nutr 133(Suppl):1477S-1480S.
33. Lai L, Bohnsack BL, Niederreither K, Hirschi KK. 2003. Retinoic acid regulates endothelial cell proliferation during vasculogenesis. Development 130:6465-6474.
34. Maisonpierre PC, Suri C, Jones PF, Bartunkova S, Wiegand SJ, Radziejewski C, Compton D, McClain J, Aldrich TH, Papadopoulos N, Daly TJ, Davis S, Sato TN, Yancopoulos GD. 1997. Angiopoietin-2, a natural antagonist for Tie2 that disrupts in vivo angiogenesis. Science 277:55-60.
35. McGrath KE, Koniski AD, Malik J, Palis J. 2003. Circulation is established in a stepwise pattern in the mammalian embryo. Blood 101:1669-1676.
36. Mercer JF, Llanos RM. 2003. Molecular and cellular aspects of copper transport in developing mammals. J Nutr 133(Suppl):1481S-1484S.
37. Moriguchi M, Nakajima T, Kimura H, Watanabe T, Takashima H, Mitsumoto Y, Katagishi T, Okanoue T, Kagawa K. 2002. The copper chelator trientine has an antiangiogenic effect against hepatocellular carcinoma, possibly through inhibition of interleukin-8 production. Int J Cancer 102:445-452.
38. Nath AK, Enciso J, Kuniyasu M, Hao XY, Madri JA, Pinter E. 2004. Nitric oxide modulates murine yolk sac vasculogenesis and rescues glucose induced vasculopathy. Development 131:2485-2496.
39. Palis J, McGrath KE, Kingsley PD. 1995. Initiation of hematopoiesis and vasculogenesis in murine yolk sac explants. Blood 86:156-163.
40. Pan Q, Kleer CG, van Golen KL, Irani J, Bottema KM, Bias C, De Carvalho M, Mesri EA, Robins DM, Dick RD, Brewer GJ, Merajver SD. 2002. Copper deficiency induced by tetrathiomolybdate suppresses tumor growth and angiogenesis. Cancer Res 62:4854-4859.
41. Prohaska JR, Brokate B. 2002. The timing of perinatal copper deficiency in mice influences offspring survival. J Nutr 132:3142-3145.
42. Rahimi N. 2006. VEGFR-1 and VEGFR-2: two non-identical twins with a unique physiognomy. Front Biosci 1:818-829.
43. Redman BG, Esper P, Pan Q, Dunn RL, Hussain HK, Chenevert T, Brewer GJ, Merajver SD. 2003. Phase II trial of tetrathiomolybdate in patients with advanced kidney cancer. Clin Cancer Res 9:1666-1672.
44. Reeves PG, DeMars LC. 2004. Copper deficiency reduces iron absorption and biological half-life in male rats. J Nutr 134:1953-1957.
45. Rossant J, Howard L. 2002. Signaling pathways in vascular development. Annu Rev Cell Dev Biol 18:541-573.
46. Sato TN, Tozawa Y, Deutsch U, Wolburg-Buchholz K, Fujiwara Y, Gendron-Maguire M, Gridley T, Wolburg H, Risau W, Qin Y. 1995. Distinct roles of the receptor tyrosine kinases Tie-1 and Tie-2 in blood vessel formation. Nature 376:70-74.
47. Sato TN, Loughna S. 2002. Vasculogenesis and angiogenesis. In: Rossant J, editor. Mouse development. New York: Academic Press, p 211-233.
48. Schuschke DA, Saari JT, Miller FN. 1995. A role for dietary copper in nitric oxide-mediated vasodilation. Microcirculation 2:371-376.
49. Schuschke DA, Percival SS, Saari JT, Miller FN. 1999. Relationship between dietary copper concentration and acetylcholine-induced vasodilation in the microcirculation of rats. Biofactors 10:321-327.
50. Sen CK, Khanna S, Venojarvi M, Trikha P, Ellison EC, Hunt TK, Roy S. 2002. Copper-induced vascular endothelial growth factor expression and wound healing. Am J Physiol Heart Circ Physiol 282:H1821-H1827.
51. Shalaby F, Rossant J, Yamaguchi TP, Gertsenstein M, Wu XF, Breitman ML, Schuh AC. 1995. Failure of blood-island formation and vasculogenesis in Flk-1-deficient mice. Nature 376:62-66.
52. Soncin F, Guitton JD, Cartwright T, Badet J. 1997. Interaction of human angiogenin with copper modulates angiogenin binding to endothelial cells. Biochem Biophys Res Commun 236:604-610.
53. Suri C, Jones PF, Patan S, Bartunkova S, Maisonpierre PC, Davis S, Sato TN, Yancopoulos GD. 1996. Requisite role of angiopoietin-1, a ligand for the TIE2 receptor, during embryonic angiogenesis. Cell 87:1171-1180.
54. Tallquist MD, Soriano P, Klinghoffer RA. 1999. Growth factor signaling pathways in vascular development. Oncogene 18:7917-7932.
55. Yancopoulos GD, Davis S, Gale NW, Rudge JS, Wiegand SJ, Holash J. 2000. Vascular-specific growth factors and blood vessel formation. Nature 407:242-248.